Dear colleagues,

Over the last years, we have observed an increasing trend in the occurrence of multidrug-resistant (MDR) bacteria in both humans and animals. Some MDR bacteria of major concern in human medicine, namely Escherichia coli producing extended-spectrum beta-lactamase (ESBL) and methicillin-resistant Staphylococcus aureus (MRSA), are increasingly reported in both food-producing and companion animals. Consequently, the possible zoonotic implications of antimicrobial resistance have attracted considerable attention from the scientific community and human and animal health professionals, as well as relevant stakeholders involved in livestock production and veterinary medicine manufacture.

ICOHAR brings together representatives from the public health, medical and veterinary sectors, and scientists working in antimicrobial drug discovery, prevention, treatment and control of multidrug-resistant bacteria.
The scope of the Conference is to share cutting-edge research and promote interdisciplinary and intersectorial collaboration in this field through a One Health approach.
The goal is to integrate complementary disciplines and sectors to develop new “green” antimicrobial drugs and strategies that will mitigate the burden of antimicrobial resistance taking into account the current concerns related to public health, animal welfare and economic sustainability of livestock production.

ICOHAR is a conference is supported by 3 distinct projects funded by the EU Commission (TRAIN-ASAP), the Danish Research Council for Strategic Research (DanCARD) and the University of Copenhagen (UC-Care), respectively, together with Danish Pig Research Centre, SEGES.

By attending this conference you will have the opportunity to appreciate the scientific outcomes achieved by over 40 young scientists employed by these projects.
An optimal balance between young and senior speakers is ensured by the presence of several famous scientists in the area of antimicrobial drug discovery and therapy, who enthusiastically accepted to contribute to this One-Health initiative.

The scientific quality of the ICOHAR programme is further enriched by the satellite symposium on Friday 2 October, focusing on the impact of antimicrobial use in animals on human health, and on the burden of human infections caused by livestock-associated MRSA.
The satellite symposium will culminate with panel discussions involving both scientists and stakeholders.

We look forward to seeing you all in September 2015 in Copenhagen!

Best regards,

Luca Guardabassi

Professor (MSO) in Antimicrobial Resistance and Antibiosis

Department of Veterinary Disease Biology

University of Copenhagen,

Niels Frimodt-Møller

Professor in Clinical Microbiology

Head of department of Clinical Microbiology

Rigshospitalet Copenhagen, Denmark

Important info

Festsalen, Copenhagen University, Frue Plads, 1168 Copenhagen K, Denmark


30 September 2015
- 2 October 2015


Download the programme here




Supporting projects


Supporting organisations


This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement N° 289285.